124 related articles for article (PubMed ID: 9321758)
41. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
[TBL] [Abstract][Full Text] [Related]
42. Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population.
Shahzad M; Yousaf S; Waryah YM; Gul H; Kausar T; Tariq N; Mahmood U; Ali M; Khan MA; Waryah AM; Shaikh RS; Riazuddin S; Ahmed ZM;
Sci Rep; 2017 Mar; 7():44185. PubMed ID: 28266639
[TBL] [Abstract][Full Text] [Related]
43. [Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].
Zhou QJ; Gong P; Jiao XR; Yang ZX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):181-185. PubMed ID: 36718709
[TBL] [Abstract][Full Text] [Related]
44. A patient with subclinical oculocutaneous albinism type 2 diagnosed on getting severely sunburned.
Kawai M; Suzuki T; Ito S; Inagaki K; Suzuki N; Tomita Y
Dermatology; 2005; 210(4):322-3. PubMed ID: 15942220
[TBL] [Abstract][Full Text] [Related]
45. [Prenatal diagnosis of oculocutaneous albinism type II and discovery of two novel mutations].
Li HY; Wei HY; Zheng H; Meng S; Jiang WY; Chen LM; Duan HL
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1123-5. PubMed ID: 17672996
[TBL] [Abstract][Full Text] [Related]
46. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
47. Albinism and disease causing pathogens in Tanzania: are alleles that are associated with OCA2 being maintained by balancing selection?
Tuli AM; Valenzuela RK; Kamugisha E; Brilliant MH
Med Hypotheses; 2012 Dec; 79(6):875-8. PubMed ID: 23063908
[TBL] [Abstract][Full Text] [Related]
48. High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients.
Rooryck C; Morice-Picard F; Lasseaux E; Cailley D; Dollfus H; Defoort-Dhellemme S; Duban-Bedu B; de Ravel TJ; Taieb A; Lacombe D; Arveiler B
Hum Genet; 2011 Feb; 129(2):199-208. PubMed ID: 21085994
[TBL] [Abstract][Full Text] [Related]
49. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
50. [Prenatal genetic diagnosis of oculocutaneous albinism type II through mutation detection combined with SNPs linkage analysis].
Chen X; Wei H; Zhou Y; Zheng H; Fang Q; Jiang W; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):140-3. PubMed ID: 24711019
[TBL] [Abstract][Full Text] [Related]
51. [A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease].
Aquaron R; Lund P; Baker C
Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390024
[TBL] [Abstract][Full Text] [Related]
52. [A de novo mutation of P gene causes oculocutaneous albinism type 2 with prenatal diagnosis].
Zhang L; Xu B; Zhong Y; Chen X; Zheng H; Jiang W; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):318-21. PubMed ID: 23744323
[TBL] [Abstract][Full Text] [Related]
53. Oculocutaneous albinism type 1A: a case report.
Karaman A
Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
[TBL] [Abstract][Full Text] [Related]
54. Mutation analysis in a family with oculocutaneous albinism manifesting in the same generation of three branches.
Preising MN; Forster H; Tan H; Lorenz B; de Jong PT; Plomp AS
Mol Vis; 2007 Oct; 13():1851-5. PubMed ID: 17960121
[TBL] [Abstract][Full Text] [Related]
55. OCA4: evidence for a founder effect for the p.D157N mutation of the MATP gene in Japanese and Korean.
Inagaki K; Suzuki T; Ito S; Suzuki N; Fukai K; Horiuchi T; Tanaka T; Manabe E; Tomita Y
Pigment Cell Res; 2005 Oct; 18(5):385-8. PubMed ID: 16162179
[TBL] [Abstract][Full Text] [Related]
56. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.
Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K
Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708
[TBL] [Abstract][Full Text] [Related]
57. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.
Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W
J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476
[TBL] [Abstract][Full Text] [Related]
58. Biology and genetics of oculocutaneous albinism and vitiligo - common pigmentation disorders in southern Africa.
Manga P; Kerr R; Ramsay M; Kromberg JG
S Afr Med J; 2013 Jul; 103(12 Suppl 1):984-8. PubMed ID: 24300644
[TBL] [Abstract][Full Text] [Related]
59. Albinism (OCA2) in Amerindians.
Woolf CM
Am J Phys Anthropol; 2005; Suppl 41():118-40. PubMed ID: 16369963
[TBL] [Abstract][Full Text] [Related]
60. Distribution of OCA2∗481Thr and OCA2∗615Arg, associated with hypopigmentation, in several additional populations.
Yuasa I; Harihara S; Jin F; Nishimukai H; Fujihara J; Fukumori Y; Takeshita H; Umetsu K; Saitou N
Leg Med (Tokyo); 2011 Jul; 13(4):215-7. PubMed ID: 21565543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
